IL1B and migraine disorder: For example, Shen et al. demonstrated that subcutaneous administration of BoNT/A into the frontal and temporal regions in an animal migraine model deactivated the nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) inflammasome and downregulated interleukin (IL)-1β expression [39].